Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Golden

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|September 4, 2010
High rate of fistula placement in a cohort of dialysis patients in a single payer systemChristopher D Blosser, Gashu Ayehu, Sam Wu, et al.
Biology|February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer DatasetsAlyssa Obermayer, Li Dong, Qianqian Hu, et al.
Coronary Artery Disease|July 20, 2002
Beta-cyclodextrin tetradecasulfate, a novel cyclic oligosaccharide, inhibits thrombus and neointimal formation after coronary vascular injuryNicolas F Meneveau, Bruce D Klugherz, Brahim Chaqour, et al.
Nucleic Acids Research|August 17, 2019
Long-read amplicon denoisingVenkatesh Kumar, Thomas Vollbrecht, Mark Chernyshev, et al.
Stroke|May 4, 2002
Bone formation in carotid plaques: a clinicopathological studyJennifer L Hunt, Ronald Fairman, Marc E Mitchell, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 31, 2017
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
Respiratory Medicine|November 8, 2016
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPDDonald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Respiratory Medicine|July 23, 2017
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]Donald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Hemodialysis International. International Symposium on Home Hemodialysis|September 4, 2010
High rate of fistula placement in a cohort of dialysis patients in a single payer systemChristopher D Blosser, Gashu Ayehu, Sam Wu, et al.
Biology|February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer DatasetsAlyssa Obermayer, Li Dong, Qianqian Hu, et al.
Coronary Artery Disease|July 20, 2002
Beta-cyclodextrin tetradecasulfate, a novel cyclic oligosaccharide, inhibits thrombus and neointimal formation after coronary vascular injuryNicolas F Meneveau, Bruce D Klugherz, Brahim Chaqour, et al.
Nucleic Acids Research|August 17, 2019
Long-read amplicon denoisingVenkatesh Kumar, Thomas Vollbrecht, Mark Chernyshev, et al.
Stroke|May 4, 2002
Bone formation in carotid plaques: a clinicopathological studyJennifer L Hunt, Ronald Fairman, Marc E Mitchell, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 31, 2017
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
Respiratory Medicine|November 8, 2016
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPDDonald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Respiratory Medicine|July 23, 2017
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]Donald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Pageof 5